DCF — ADVENTHEALTH MANCHESTER
Enterprise Value: $-125.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-125.3M
Enterprise Value
$-39.5M
PV of Cash Flows
$-85.7M
PV of Terminal Value
$-138.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $75.2M | $-7.9M | -10.0% | $-11.0M | $-10.0M |
| Year 2 | $77.5M | $-7.3M | -9.0% | $-10.6M | $-8.8M |
| Year 3 | $79.8M | $-6.7M | -8.0% | $-10.1M | $-7.6M |
| Year 4 | $82.2M | $-6.5M | -8.0% | $-10.0M | $-6.8M |
| Year 5 | $84.7M | $-6.5M | -8.0% | $-10.1M | $-6.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-125.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$73.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10950538095435927
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5